Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Dermpath & Clinic: In situ melanoma arising within a speckled lentiginous nevus.

Frings VG, Goebeler M, Kneitz H.

Eur J Dermatol. 2018 Dec 1;28(6):857-859. doi: 10.1684/ejd.2018.3466. No abstract available.

PMID:
30698152
2.

Altered NOX expression does not seem to account for epidermal NLRP3 inflammasome activation in Hidradenitis Suppurativa.

Frings VG, Sennefelder H, Presser D, Goebeler M, Schmidt M.

Br J Dermatol. 2019 Jan 18. doi: 10.1111/bjd.17647. [Epub ahead of print]

PMID:
30657189
3.

The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.

Appenzeller S, Gesierich A, Thiem A, Hufnagel A, Jessen C, Kneitz H, Regensburger M, Schmidt C, Zirkenbach V, Bischler T, Schilling B, Siedel C, Goebeler ME, Houben R, Schrama D, Gehrig A, Rost S, Maurus K, Bargou R, Rosenwald A, Schartl M, Goebeler M, Meierjohann S.

Cancer. 2019 Feb 15;125(4):586-600. doi: 10.1002/cncr.31843. Epub 2018 Dec 18.

PMID:
30561760
4.

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.

Michel C, Burchert A, Hochhaus A, Saussele S, Neubauer A, Lauseker M, Krause SW, Kolb HJ, Hossfeld DK, Nerl C, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Balleisen L, Goebeler ME, Hänel M, Ho A, Dengler J, Falge C, Möhle R, Kremers S, Kneba M, Stegelmann F, Köhne CH, Lindemann HW, Waller CF, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Schenk M, Brossart P, Wündisch T, Geer T, Bildat S, Schäfer E, Hasford J, Hehlmann R, Pfirrmann M.

Haematologica. 2018 Dec 4. pii: haematol.2018.206797. doi: 10.3324/haematol.2018.206797. [Epub ahead of print]

5.

Perforierender Nasenwanddefekt: Verschluss mittels Kombinationslappenplastik.

Reichel A, Goebeler M, Weyandt G.

J Dtsch Dermatol Ges. 2018 Nov;16(11):1399-1401. doi: 10.1111/ddg.13678_g. No abstract available.

PMID:
30395405
6.

Combined, two-layered reconstruction technique for full-thickness nasal defects.

Reichel A, Goebeler M, Weyandt G.

J Dtsch Dermatol Ges. 2018 Nov;16(11):1399-1401. doi: 10.1111/ddg.13678. Epub 2018 Oct 23. No abstract available.

PMID:
30351521
7.

Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies.

von Tresckow B, Sayehli C, Aulitzky WE, Goebeler ME, Schwab M, Braz E, Krauss B, Krauss R, Hermann F, Bartz R, Engert A.

Eur J Haematol. 2019 Feb;102(2):163-173. doi: 10.1111/ejh.13188. Epub 2019 Jan 7.

PMID:
30347469
8.

Aberrant B-cell Subsets and Immunoglobulin Levels in Patients with Moderate-to-severe Psoriasis.

Kahlert K, Grän F, Muhammad K, Benoit S, Serfling E, Goebeler M, Kerstan A.

Acta Derm Venereol. 2019 Feb 1;99(2):226-227. doi: 10.2340/00015555-3069. No abstract available.

9.

A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors.

Kebenko M, Goebeler ME, Wolf M, Hasenburg A, Seggewiss-Bernhardt R, Ritter B, Rautenberg B, Atanackovic D, Kratzer A, Rottman JB, Friedrich M, Vieser E, Elm S, Patzak I, Wessiepe D, Stienen S, Fiedler W.

Oncoimmunology. 2018 Apr 18;7(8):e1450710. doi: 10.1080/2162402X.2018.1450710. eCollection 2018.

10.

Blasenbildende Autoimmunerkrankungen: zielgerichtete Diagnostik und multimodale Therapie.

Goebeler M.

J Dtsch Dermatol Ges. 2018 Sep;16(9):1071-1072. doi: 10.1111/ddg.13645. No abstract available.

PMID:
30179328
11.

Dermpath & Clinic: Juvenile xanthogranuloma.

Frings VG, Goebeler M, Wobser M.

Eur J Dermatol. 2018 Jun 1;28(3):429-431. doi: 10.1684/ejd.2018.3362. No abstract available.

PMID:
30106001
12.

Paraproteinaemia in Primary Cutaneous Marginal Zone Lymphoma.

Frings VG, Röding K, Strate A, Rosenwald A, Roth S, Kneitz H, Goebeler M, Geissinger E, Wobser M.

Acta Derm Venereol. 2018 Nov 5;98(10):956-962. doi: 10.2340/00015555-3016.

13.

Large Nasal Defects with Exposed Cartilage: The Folded Transposition Flap as an Innovative Alternative to the Paramedian Forehead Flap.

Schäfer K, Rudolph C, Cotofana S, Goebeler M, Weyandt G.

Dermatology. 2018;234(3-4):99-104. doi: 10.1159/000490907. Epub 2018 Jul 31.

PMID:
30064128
14.

Nocardiosis in a patient with anti-PD-1-associated colitis treated with infliximab.

Glutsch V, Gesierich A, Goebeler M, Forster J, Schilling B.

Eur J Cancer. 2018 Sep;101:284-286. doi: 10.1016/j.ejca.2018.06.014. Epub 2018 Jul 13. No abstract available.

PMID:
30017385
15.

Kinderwunsch bei Lupus erythematodes - eine medizinische Herausforderung.

Grän F, Schwaneck EC, Rehn M, Strate A, Goebeler M, Benoit S.

J Dtsch Dermatol Ges. 2018 Jul;16(7):913-916. doi: 10.1111/ddg.13577_g. No abstract available.

PMID:
29989370
16.

Pregnancy and lupus erythematosus - a therapeutic challenge.

Grän F, Schwaneck EC, Rehn M, Strate A, Goebeler M, Benoit S.

J Dtsch Dermatol Ges. 2018 Jul;16(7):913-916. doi: 10.1111/ddg.13577. Epub 2018 Jul 4. Review. No abstract available.

PMID:
29972730
17.

Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.

Milsch L, Gesierich A, Kreft S, Livingstone E, Zimmer L, Goebeler M, Schadendorf D, Schilling B.

Eur J Cancer. 2018 Aug;99:58-65. doi: 10.1016/j.ejca.2018.05.012. Epub 2018 Jun 12.

PMID:
29906735
18.

Differenzialdiagnostische Bedeutung epithelialer und stromaler CD10-Expression in Tumoren trichogenen Ursprungs.

Kneitz H, Fetzer S, Goebeler M, Bröcker EB.

J Dtsch Dermatol Ges. 2018 Jun;16(6):719-729. doi: 10.1111/ddg.13547_g. No abstract available.

PMID:
29873928
19.

Differential diagnostic significance of epithelial and stromal CD10 expression in tumors of trichogenic origin.

Kneitz H, Fetzer S, Goebeler M, Bröcker EB.

J Dtsch Dermatol Ges. 2018 Jun;16(6):719-728. doi: 10.1111/ddg.13547.

PMID:
29873924
20.

Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors.

Thiem A, Schummer P, Ueberschaar S, Kerstan A, Kneitz H, Schrama D, Appenzeller S, Meierjohann S, Schilling B, Goebeler M, Gesierich A.

Melanoma Res. 2018 Oct;28(5):465-468. doi: 10.1097/CMR.0000000000000458.

PMID:
29781871
21.

Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma.

Haug V, Behle V, Benoit S, Kneitz H, Schilling B, Goebeler M, Gesierich A.

Br J Dermatol. 2018 Oct;179(4):993-994. doi: 10.1111/bjd.16780. Epub 2018 Jul 23. No abstract available.

PMID:
29758087
22.

Twenty Years' Experience with Anaphylaxis-Like Reactions to Local Anesthetics: Genuine Allergy is Rare.

Trautmann A, Goebeler M, Stoevesandt J.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2051-2058.e1. doi: 10.1016/j.jaip.2018.04.005. Epub 2018 Apr 12.

PMID:
29655774
23.

Structured Diagnostic Approach and Risk Assessment in Mucous Membrane Pemphigoid with Oesophageal Involvement.

Benoit S, Scheurlen M, Goebeler M, Stoevesandt J.

Acta Derm Venereol. 2018 Jul 11;98(7):660-666. doi: 10.2340/00015555-2938.

24.

The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization.

Adam C, Glück L, Ebert R, Goebeler M, Jakob F, Schmidt M.

Bone. 2018 Jun;111:49-58. doi: 10.1016/j.bone.2018.03.020. Epub 2018 Mar 19.

PMID:
29567200
25.

Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.

Rinaldetti S, Pfirrmann M, Manz K, Guilhot J, Dietz C, Panagiotidis P, Spiess B, Seifarth W, Fabarius A, Müller M, Pagoni M, Dimou M, Dengler J, Waller CF, Brümmendorf TH, Herbst R, Burchert A, Janβen C, Goebeler ME, Jost PJ, Hanzel S, Schafhausen P, Prange-Krex G, Illmer T, Janzen V, Klausmann M, Eckert R, Büschel G, Kiani A, Hofmann WK, Mahon FX, Saussele S.

Clin Lymphoma Myeloma Leuk. 2018 Apr;18(4):266-271. doi: 10.1016/j.clml.2018.02.004. Epub 2018 Feb 8.

26.

Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma.

Maurus K, Appenzeller S, Roth S, Kuper J, Rost S, Meierjohann S, Arampatzi P, Goebeler M, Rosenwald A, Geissinger E, Wobser M.

J Invest Dermatol. 2018 Jul;138(7):1573-1581. doi: 10.1016/j.jid.2018.02.015. Epub 2018 Feb 23.

PMID:
29481902
27.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Schütz C, Inselmann S, Saussele S, Dietz CT, Müller MC, Eigendorff E, Brendel CA, Metzelder SK, Brümmendorf TH, Waller C, Dengler J, Goebeler ME, Herbst R, Freunek G, Hanzel S, Illmer T, Wang Y, Lange T, Finkernagel F, Hehlmann R, Huber M, Neubauer A, Hochhaus A, Guilhot J, Mahon FX, Pfirrmann M, Burchert A.

Leukemia. 2018 Apr;32(4):1054. doi: 10.1038/leu.2017.348. Epub 2018 Jan 30.

PMID:
29381150
28.

[Lichenoid diseases].

Vogt T, Goebeler M.

Hautarzt. 2018 Feb;69(2):98-99. doi: 10.1007/s00105-018-4123-8. German. No abstract available.

PMID:
29330578
29.

Anti-desmoglein 1 IgG/IgA pemphigus associated with thymoma.

Reichel A, Benoit S, Giner T, Schmidt E, Goebeler M, Stoevesandt J.

J Dtsch Dermatol Ges. 2017 Nov;15(11):1147-1148. doi: 10.1111/ddg.13351. Epub 2017 Oct 14. No abstract available.

PMID:
29030953
30.

Dermpath & Clinic: Giant trichoblastoma of the leg.

Frings VG, Goebeler M, Kneitz H.

Eur J Dermatol. 2017 Aug 1;27(4):447-448. doi: 10.1684/ejd.2017.3108. No abstract available.

PMID:
28862138
31.

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group.

Hoechstetter MA, Busch R, Eichhorst B, Bühler A, Winkler D, Eckart MJ, Vehling-Kaiser U, Schimke H, Jäger U, Hurtz HJ, Hopfinger G, Hartmann F, Fuss H, Abenhardt W, Blau I, Freier W, Müller L, Goebeler M, Wendtner CM, Bahlo J, Fischer K, Bentz M, Emmerich B, Döhner H, Hallek M, Stilgenbauer S.

Leukemia. 2017 Dec;31(12):2833-2837. doi: 10.1038/leu.2017.246. Epub 2017 Aug 14. No abstract available.

PMID:
28804126
32.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Hehlmann R, Lauseker M, Saußele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Müller MC, Jeromin S, Proetel U, Kohlbrenner K, Voskanyan A, Rinaldetti S, Seifarth W, Spieß B, Balleisen L, Goebeler MC, Hänel M, Ho A, Dengler J, Falge C, Kanz L, Kremers S, Burchert A, Kneba M, Stegelmann F, Köhne CA, Lindemann HW, Waller CF, Pfreundschuh M, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Pezzutto A, Schenk M, Brossart P, Geer T, Bildat S, Schäfer E, Hochhaus A, Hasford J.

Leukemia. 2017 Nov;31(11):2398-2406. doi: 10.1038/leu.2017.253. Epub 2017 Aug 14.

33.

Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab.

Thiem A, Kneitz H, Schummer P, Herz S, Schrama D, Houben R, Goebeler M, Schilling B, Gesierich A.

Acta Derm Venereol. 2017 Nov 15;97(10):1252-1254. doi: 10.2340/00015555-2757. No abstract available.

34.

Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma Registry.

Gassenmaier M, Eigentler TK, Keim U, Goebeler M, Fiedler E, Schuler G, Leiter U, Weide B, Grischke EM, Martus P, Garbe C.

J Invest Dermatol. 2017 Dec;137(12):2570-2577. doi: 10.1016/j.jid.2017.07.006. Epub 2017 Jul 21.

35.

Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis.

Schmidt T, Hoch M, Lotfi Jad SS, Solimani F, Di Zenzo G, Marzano AV, Goebeler M, Cozzani E, Kern JS, Sitaru C, Lakoš Jukić I, Sárdy M, Uzun S, Jedlickova H, Gläser R, Kaneda M, Eming R, Göpel G, Ishii N, Greene B, Hashimoto T, Hertl M.

Br J Dermatol. 2017 Dec;177(6):1683-1692. doi: 10.1111/bjd.15800. Epub 2017 Dec 1.

PMID:
28703393
36.

Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus.

Walter E, Vielmuth F, Rotkopf L, Sárdy M, Horváth ON, Goebeler M, Schmidt E, Eming R, Hertl M, Spindler V, Waschke J.

Sci Rep. 2017 Jun 15;7(1):3579. doi: 10.1038/s41598-017-03697-7.

37.

[Sarcoidosis : Dermatological view of a rare multisystem disease].

Giner T, Benoit S, Kneitz H, Goebeler M.

Hautarzt. 2017 Jul;68(7):526-535. doi: 10.1007/s00105-017-4005-5. Review. German.

PMID:
28573316
38.

Atypical Clinical and Serological Manifestation of Pemphigus Vegetans: A Case Report and Review of the Literature.

Mergler R, Kerstan A, Schmidt E, Goebeler M, Benoit S.

Case Rep Dermatol. 2017 Apr 27;9(1):121-130. doi: 10.1159/000468919. eCollection 2017 Jan-Apr. Review.

39.

[Progressive ulceration of the periorbital region].

Frings A, Frings V, Geerling G, Goebeler M, Schargus M.

Ophthalmologe. 2018 Feb;115(2):157-160. doi: 10.1007/s00347-017-0512-0. German. No abstract available.

PMID:
28526971
40.

Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis.

Behle V, von Braunmühl T, Sayehli C, Gesierich A, Goebeler M, Geissinger E, Wobser M.

Acta Derm Venereol. 2017 Aug 31;97(8):973-975. doi: 10.2340/00015555-2700. No abstract available.

41.

"Treating Through" Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas.

Trautmann A, Benoit S, Goebeler M, Stoevesandt J.

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1650-1656. doi: 10.1016/j.jaip.2017.03.032. Epub 2017 May 9.

PMID:
28499779
42.

Dermpath & Clinic: Multiple reactive eccrine syringofibroadenomas.

Frings VG, Trautmann A, Goebeler M, Wobser M.

Eur J Dermatol. 2017 Feb 1;27(1):102-104. doi: 10.1684/ejd.2017.2965. No abstract available.

PMID:
28218061
43.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Schütz C, Inselmann S, Saussele S, Dietz CT, Mu Ller MC, Eigendorff E, Brendel CA, Metzelder SK, Bru Mmendorf TH, Waller C, Dengler J, Goebeler ME, Herbst R, Freunek G, Hanzel S, Illmer T, Wang Y, Lange T, Finkernagel F, Hehlmann R, Huber M, Neubauer A, Hochhaus A, Guilhot J, Xavier Mahon F, Pfirrmann M, Burchert A.

Leukemia. 2017 Apr;31(4):829-836. doi: 10.1038/leu.2017.9. Epub 2017 Jan 11. Erratum in: Leukemia. 2018 Jan 30;:.

PMID:
28074067
44.

Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir.

Toksoy A, Sennefelder H, Adam C, Hofmann S, Trautmann A, Goebeler M, Schmidt M.

J Biol Chem. 2017 Feb 17;292(7):2805-2814. doi: 10.1074/jbc.M116.749473. Epub 2017 Jan 5.

45.

Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.

Almanzar G, Klein M, Schmalzing M, Hilligardt D, El Hajj N, Kneitz H, Wild V, Rosenwald A, Benoit S, Hamm H, Tony HP, Haaf T, Goebeler M, Prelog M.

Int Arch Allergy Immunol. 2016;171(2):141-154. doi: 10.1159/000450949. Epub 2016 Dec 1.

46.

Aggregierte orangefarbene Papeln im Gesicht.

Wobser M, Geissinger E, Roth S, Goebeler M, Trautmann A.

J Dtsch Dermatol Ges. 2016 Nov;14(11):1152-1154. doi: 10.1111/ddg.12528_g. No abstract available.

PMID:
27879088
47.

Agminated orange papules on the face.

Wobser M, Geissinger E, Roth S, Goebeler M, Trautmann A.

J Dtsch Dermatol Ges. 2016 Nov;14(11):1149-1151. doi: 10.1111/ddg.12528. No abstract available.

PMID:
27879070
48.

Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal-zone lymphoma with a nonclass-switched immunoglobulin M immunophenotype.

Wobser M, Maurus K, Roth S, Appenzeller S, Weyandt G, Goebeler M, Rosenwald A, Geissinger E.

Br J Dermatol. 2017 Aug;177(2):564-566. doi: 10.1111/bjd.15183. Epub 2017 Jul 31. No abstract available.

PMID:
27861728
49.

Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20.

Frings VG, Roth S, Riedmiller AL, Schäfer K, Goebeler M, Rosenwald A, Geissinger E, Wobser M.

Acta Derm Venereol. 2017 Apr 6;97(4):534-536. doi: 10.2340/00015555-2576. No abstract available.

50.

Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma.

Toksoy A, Strifler S, Benoit S, Grigoleit GU, Knop S, Mielke S, Buder-Bakhaya K, Roth S, Goebeler M, Rosenwald A, Geissinger E, Wobser M.

Acta Derm Venereol. 2017 Mar 10;97(3):379-380. doi: 10.2340/00015555-2564. No abstract available.

Supplemental Content

Loading ...
Support Center